Renaissance Technologies’s HilleVax HLVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-54,100
Closed -$108K 3660
2025
Q2
$108K Buy
54,100
+26,500
+96% +$48.5K ﹤0.01% 3288
2025
Q1
$40K Buy
+27,600
New +$51K ﹤0.01% 3309
2024
Q3
Sell
-56,700
Closed -$820K 3675
2024
Q2
$820K Buy
56,700
+30,900
+120% +$425K ﹤0.01% 2436
2024
Q1
$429K Buy
+25,800
New +$413K ﹤0.01% 2921

Renaissance Technologies's HLVX Position: Q3 2025 in Review

Renaissance Technologies sold out of HilleVax (HLVX) in Q3 2025, closing a stake of 54,100 shares — an estimated $108K sold.

Renaissance Technologies first reported a position in HLVX in Q1 2024 and held it in 4 quarters. The position peaked at $820K in Q2 2024. 1 fund tracked by Wall St. Rank holds HLVX as of Q3 2025.

  • Renaissance Technologies reported no remaining HilleVax position as of Q3 2025 after selling out during the quarter.
  • Renaissance Technologies sold 54,100 HilleVax shares in Q3 2025, an estimated $108K.
  • Renaissance Technologies first reported a position in HilleVax in Q1 2024 and held it in 4 quarters.
  • Renaissance Technologies's HilleVax position peaked at $820K in Q2 2024.
  • 1 fund tracked by Wall St. Rank held HilleVax as of Q3 2025.

Based on Renaissance Technologies's 13F filing for Q3 2025, filed 13 Nov 2025.